SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited has announced the lapse of 10,000 Share Options under its Post-IPO Option Plan, updating its securities status as part of the ongoing privatisation proposal by Silver Pegasus Investment Limited. The company now has 630,296,632 Shares issued and 66,477,432 Share Options outstanding after the lapse. This update follows a series of announcements made in compliance with the Hong Kong Code on Takeovers and Mergers.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.